Accustem Sciences Inc.
Other OTCTotal Valuation
Accustem Sciences Inc. carries a market capitalization of 2.37M, placing it among publicly traded companies globally.
| Market Cap | 2.37M |
| Enterprise Value | N/A |
Share Statistics
Accustem Sciences Inc. currently has 16.07M shares outstanding.
| Shares Outstanding | 16.07M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -1.11 |
| P/TBV Ratio | -1.11 |
| P/FCF Ratio | -3.81 |
| P/OCF Ratio | -3.81 |
Financial Position
Accustem Sciences Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -102.66 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Accustem Sciences Inc.'s stock has declined approximately -90.4871% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | -90.4871% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.30 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -1.75M, while operating income came in at -1.75M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.75M |
| Pretax Income | -1.65M |
| Net Income | -1.65M |
| EBITDA | -1.75M |
| EBIT | -1.75M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
Total book value stands at -4.12M, with working capital of -5.62M providing operational flexibility.
| Cash & Cash Equivalents | 12,928.00 |
| Total Debt | N/A |
| Net Debt | 49,713.00 |
| Equity (Book Value) | -4.12M |
| Book Value Per Share | -0.26 |
| Working Capital | -5.62M |
Cash Flow
Accustem Sciences Inc. produced -1.20M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.20M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.20M |
| FCF Per Share | -0.07 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -25.86 |
| FCF Yield | -26.27 |
Scores
Accustem Sciences Inc. posts an Altman Z-Score of -16.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -16.48 |